JP2017189179A5 - - Google Patents

Download PDF

Info

Publication number
JP2017189179A5
JP2017189179A5 JP2017146473A JP2017146473A JP2017189179A5 JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5 JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5
Authority
JP
Japan
Prior art keywords
cell
host cell
virus
bacterial
bacterial dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017146473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017189179A (ja
JP6666311B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017189179A publication Critical patent/JP2017189179A/ja
Publication of JP2017189179A5 publication Critical patent/JP2017189179A5/ja
Application granted granted Critical
Publication of JP6666311B2 publication Critical patent/JP6666311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017146473A 2009-07-31 2017-07-28 逆遺伝学系 Active JP6666311B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27315109P 2009-07-31 2009-07-31
US61/273,151 2009-07-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012522275A Division JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系

Publications (3)

Publication Number Publication Date
JP2017189179A JP2017189179A (ja) 2017-10-19
JP2017189179A5 true JP2017189179A5 (enExample) 2018-02-01
JP6666311B2 JP6666311B2 (ja) 2020-03-13

Family

ID=43018886

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系
JP2017146473A Active JP6666311B2 (ja) 2009-07-31 2017-07-28 逆遺伝学系

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系

Country Status (8)

Country Link
US (2) US9821052B2 (enExample)
EP (1) EP2459722B1 (enExample)
JP (3) JP2013500712A (enExample)
KR (1) KR20120039047A (enExample)
CN (2) CN104862335A (enExample)
AU (1) AU2010277310B2 (enExample)
CA (1) CA2769673A1 (enExample)
WO (1) WO2011012999A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323582B1 (ko) 2011-03-17 2013-10-30 충북대학교 산학협력단 Vero 세포 유래의 polⅠ 프로모터 및 이를 포함하는 재조합 벡터
WO2013101783A2 (en) 2011-12-30 2013-07-04 Bio-Rad Laboratories, Inc. Methods and compositions for performing nucleic acid amplification reactions
CN103608453B (zh) 2012-03-02 2018-07-24 思齐乐 流感病毒重配
KR20150110494A (ko) 2012-12-03 2015-10-02 노파르티스 아게 재배열 인플루엔자 a 바이러스
US20140274806A1 (en) 2013-03-15 2014-09-18 Synthetic Genomics Vaccines Influenza virus reassortment
MX2015009330A (es) * 2013-01-23 2016-04-15 Novartis Ag Reordenamiento del virus de influenza.
SG11201507454XA (en) 2013-03-13 2015-10-29 Novartis Ag Influenza b virus reassortment
WO2014145261A2 (en) * 2013-03-15 2014-09-18 University Of Maryland Methods and compositions for in vivo immune stimulation and antigen production
DE202013005100U1 (de) 2013-06-05 2013-08-26 Novartis Ag Influenza Virus Reassortierung
DE202013005130U1 (de) 2013-06-05 2013-09-10 Novartis Ag Influenza Virus Reassortierung
CN105722976A (zh) 2013-06-06 2016-06-29 诺华股份有限公司 流感病毒重配
MX2017012389A (es) * 2015-03-27 2018-09-19 Cadila Healthcare Ltd Vacuna del virus de la parotiditis recombinante jeryl lynn2.
US10726110B2 (en) * 2017-03-01 2020-07-28 Seven Bridges Genomics, Inc. Watermarking for data security in bioinformatic sequence analysis
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
CN114040979B (zh) * 2019-06-21 2024-06-28 国立大学法人大阪大学 稳定地保持外源基因的人工重组rna病毒的制作方法
CN110305854B (zh) * 2019-07-18 2023-09-15 山东中医药大学 一种携带荧光素酶的重组h3n2亚型流感病毒、构建方法及应用
EP4061930A1 (en) 2019-11-18 2022-09-28 Seqirus Pty Ltd Method for producing reassortant influenza viruses
CN114395568A (zh) * 2021-10-29 2022-04-26 扬州大学 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
WO1999050419A2 (en) * 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
DE69937999T2 (de) 1998-06-12 2009-01-29 Avir Green Hills Biotechnology Research Development Trade Ag Interferon induzierende genetisch veränderte attenuierte viren
JP4837827B2 (ja) 1998-06-12 2011-12-14 マウント シナイ スクール オブ メディシン 新規なウイルス増殖方法およびそのためのインターフェロン欠損培養基
GB9916794D0 (en) * 1999-07-16 1999-09-22 Isis Innovation In vitro virus reconstitution
PL355287A1 (en) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
KR100797547B1 (ko) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
ES2319864T3 (es) 2000-04-28 2009-05-14 St. Jude Children's Research Hospital Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
WO2001090340A2 (en) * 2000-05-21 2001-11-29 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
CA2438960A1 (en) 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
EP2281573A3 (en) 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
AU2003270099A1 (en) 2002-09-04 2004-03-29 Polymun Scientific Immunbiologische Forschung Gmbh Generation of recombinant influenza virus using baculovirus delivery vector
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
JP2007537760A (ja) 2004-05-20 2007-12-27 アイディー バイオメディカル コーポレイション インフルエンザワクチンを製造するためのプロセス
EA200701097A1 (ru) * 2004-11-19 2007-10-26 Висконсин Эламни Рисёч Фаундэйшн Рекомбинантные векторы вируса гриппа с тандемными транскрипционными единицами
DK2368975T3 (en) 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses
EP2295542B1 (en) 2004-12-24 2013-01-30 Abbott Biologicals B.V. Rescue of influenza virus
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
EP1917352A4 (en) 2005-06-21 2009-03-25 Medimmune Vaccines Inc METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
ES2525518T3 (es) 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
DK2016194T3 (en) 2006-04-19 2015-06-15 Medimmune Llc METHODS AND COMPOSITIONS FOR EXPRESSION OF VIRAL NEGATIVE SENSE RNA IN DOG CELLS
EA015817B1 (ru) 2006-10-12 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
PT2121011E (pt) 2006-12-06 2014-07-31 Novartis Ag Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
EP2045323A1 (en) * 2007-10-05 2009-04-08 Avir Green Hills Biotechnology Research Development Trade Ag Linear expression constructs for production of influenza virus particles
JP5618413B2 (ja) 2007-10-08 2014-11-05 シンセティック ゲノミクス、インク. 大型核酸のアッセンブリー
CN101302499A (zh) * 2008-06-30 2008-11-12 中国科学院广州生物医药与健康研究院 一种流感病毒疫苗种子株的制备方法
EP2233568A1 (en) * 2009-03-19 2010-09-29 Avir Green Hills Biotechnology Research Development Trade AG Novel method for generation of RNA virus

Similar Documents

Publication Publication Date Title
JP2017189179A5 (enExample)
Kobayashi et al. An improved reverse genetics system for mammalian orthoreoviruses
JP2015119730A5 (enExample)
Zhou et al. Characterization of uncultivable bat influenza virus using a replicative synthetic virus
Sun et al. Rapid construction of complex plant RNA virus infectious cDNA clones for agroinfection using a yeast-E. coli-Agrobacterium shuttle vector
JP2019011344A5 (enExample)
JP2016509864A5 (enExample)
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
Zhang et al. Wheat yellow mosaic virus NIb interacting with host light induced protein (LIP) facilitates its infection through perturbing the abscisic acid pathway in wheat
JP2016521553A5 (enExample)
JP2010042030A5 (enExample)
RU2008101367A (ru) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
RU2008145226A (ru) Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
Griffin et al. Fitness determinants of influenza A viruses
AU2016203557B2 (en) Plasmids and method for obtaining viral particles
JP2016501020A5 (enExample)
Mostafa et al. Efficient generation of recombinant influenza a viruses employing a new approach to overcome the genetic instability of HA segments
WO2013030176A3 (en) Live attenuated influenza virus
Shao et al. An efficient and rapid influenza gene cloning strategy for reverse genetics system
Lee Reverse genetics of influenza virus
Feng et al. Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression
Park et al. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A (H7N9) virus in guinea pigs
CN104195154A (zh) 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用
CN105671002B (zh) H9n2亚型禽流感病毒细胞高产疫苗株构建及应用
Froggatt et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity